Diabetes, Obesity and Brain Function
Fri, October 11, 2013 • 8:00 AM - 7:30 PM • Marriott Crystal Gateway, 1700 Jefferson Davis Highway Arlington, VA 22202
Obesity and diabetes prevalence rates have skyrocketed during the last decade. While we have some information about each of the disrupted peripheral physiological mechanisms associated with obesity and diabetes, very little is known about the pathways that connect these syndromes to brain vulnerability and cognitive impairment.
This meeting is intended to create a unique atmosphere for information sharing and small group interaction, as a multi-disciplinary group of speakers and audience participants explore the issues surrounding this epidemic. Investigators and healthcare providers from a variety of backgrounds, including Medicine, Nursing, Pharmacy, Psychology, Psychiatry, Epidemiology, Cognitive Neuroscience, Neurology, and Public Health will be represented.
Be a part of this meeting, and you will benefit from opportunities to learn about the latest scientific discoveries, interact with leaders in the field, and discuss how your own research and clinical work can be enhanced by what you learn and share. A special panel discussion will highlight funding opportunities available for research in these areas.
Topics and Speakers: see reverse for a complete listing
Goals of the meeting: The goals of this one-day meeting are to: provide an overview of current high-impact topics and active debates in the field of neural consequences of obesity, diabetes and their related complications; facilitate discussion among the participants; inspire new investigators; foster collaborations; and chart future directions for the field.
Knowledge / Content Objectives:
* Describe brain pathways that control food intake and reward and how they are altered by the food environment.
* Explain how glucose metabolism influences reward processing.
* Explain how the healthy brain develops and matures in adolescence and how metabolic disturbances affect this maturation process.
* Describe the impact of obesity, diabetes, and metabolic dysregulation on neurobehavioral outcomes and cognition in people as they age.
* Identify the pros and cons of surgical vs. non-surgical interventions for diabetes and obesity and their implications for brain adaptation and cognitive health.
Clinical Practice / Treatment Objectives:
* Describe how models of neuroplasticity and cognitive aging can inform treatment of diabetes, obesity and metabolic syndrome.
* Identify intervention components that derive from models of neuroplasticity and cognitive aging.
* Recognize early brain vulnerability in patients.
* Incorporate assessment of modifiable risk factors for cognitive decline into clinical practice.
*Select appropriate treatment targets to preserve cognitive function in clinical settings.
Hotel information: This meeting will be held at the Marriott Crystal Gateway, 1700 Jefferson Davis Highway, Arlington, VA 22202. The APS group rate is $179 single/double. For reservations, please visit www.psychosomatic.org